Table 2 Functional and safety outcomes for the entire cohort and subgroups
From: A study on endovascular treatment alone and bridging treatment for acute ischemic stroke
EV-Only (n = 78) | IV + EV (n = 62) | OR(95% CI) | p Value | ||
|---|---|---|---|---|---|
Unadjusted | Adjusted | ||||
Primary outcome | |||||
mRS at 90 d Median score (IQR) | 2 (0–6) | 2 (0–6) | 1.09 (− 0.50–0.68) | 0.81 (− 0.86–0.43) | 0.52 |
Secondary outcomes | |||||
mRS 0–2 at 90 d—no./total no. (%) | 29 (37.2) | 27 (43.5) | 1.30 (0.66–2.57) | 1.72 (0.78–3.78) | 0.18 |
Change in NIHSS score at 24 h Median (IQR)‡ | 2(− 30–24) | 0 (− 24–16) | 0.12 | ||
Change in NIHSS score at 7d Median (IQR)‡ | 7(− 30–26) | 4 (− 24–23) | 0.15 | ||
mTICI score of 2b or 3—no./total no. (%) | 65 (83.3) | 49 (79.0) | 0.69 (0.29–1.59) | 0.59 (0.23–1.55) | 0.29 |
Safety outcomes | |||||
Mortality at 90 d—no/total no. (%) | 14 (17.9) | 12 (19.4) | 1.2 (0.50–2.86) | 1.56 (0.58–4.21) | 0.38 |
Hemorrhage—no./total no. (%) | 2 (2.6) | 7 (11.3) | 4.8 (0.97–24.18) | 8.21 (1.28–52.82) | 0.03 |